Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)

NCT01162941 is registered in ClinicalTrials.gov with Cooperative Study Group A for Hematology as lead sponsor.

NCT NCT01162941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01162941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)
Lead sponsor
Cooperative Study Group A for Hematology
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2010
Completion date
January 31, 2012
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia